Synopsis of recent research by authors named "Ji-Ryoun Gong"
- Ji-Ryoun Gong's research primarily focuses on health economics and pharmacoeconomic evaluations, with significant attention on utility measures for breast cancer and the reimbursement landscape for pharmaceuticals in South Korea.
- A meta-regression analysis of utility weights for breast cancer indicated varying impacts based on study characteristics, highlighting the importance of patient experience in determining these utility values.
- Gong's studies examine the effects of South Korean policy changes on pharmaceutical reimbursement, demonstrating that newer drugs tend to receive more positive reimbursement decisions, shedding light on the evolving drug accessibility landscape.*